Sertraline for the treatment of depression in Parkinson's disease.
about
Therapies for depression in Parkinson's diseasePramipexole-induced somnolence and episodes of daytime sleep.Treatment of depression in comorbid medical illness.Extrapyramidal symptoms and antidepressant drugs: neuropharmacological aspects of a frequent interaction in the elderly.Depression rating scales in Parkinson's disease: critique and recommendations.A meta-analysis of randomised placebo-controlled treatment trials for depression and anxiety in Parkinson's diseaseMonoamine reuptake inhibitors in Parkinson's disease.Escitalopram for major depression in Parkinson's disease: an open-label, flexible-dosage study.Apathy and anhedonia in Parkinson's disease.Antidepressant studies in Parkinson's disease: a review and meta-analysis.Treatments for behavioural disorders in neurodegenerative diseases: drug development strategies.Depression in Parkinson's disease: health risks, etiology, and treatment options.Management of the behavioral aspects of Parkinson's disease.Depression in Parkinson's disease: identification and management.The serotonergic system in motor and non-motor manifestations of Parkinson's disease.Effect of sertraline on proliferation and neurogenic differentiation of human adipose-derived stem cellsUse of serotonergic antidepressants and St John's wort in older Australians: a population-based cohort study.The effects of antidepressants in Parkinson's disease: a meta-analysis.Imaging the Etiology of Apathy, Anxiety, and Depression in Parkinson's Disease: Implication for Treatment.Depression and Parkinson's disease: a new look at an old problem.Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease.The effect of pregnancy in Parkinson's disease.S-Adenosyl-Methionine improves depression in patients with Parkinson's disease in an open-label clinical trial.
P2860
Q24248733-0B9DBE18-A1C0-4C96-88D2-7F8A7B3DC324Q31422765-17E6145A-1E89-4449-B0AB-701B76C158BBQ34181825-3562BEA8-9912-4F91-917F-9C7213DC6C0AQ34228583-201C5FEC-C3C1-48B5-964D-D2B30C082010Q34578187-737DDD53-5F8E-43EE-A7CF-55CDE6A85979Q35043846-F348530D-4F51-433D-9D02-92A0046051B1Q35165280-9E028246-B9E5-42E7-8D5E-38584E668BB4Q35567191-8915D065-41B0-4E16-81C4-608041969FD7Q35687306-66A3EDEE-230C-435D-B617-E41BB90BEF91Q36008775-6502CE08-9A38-43D5-9D07-A756CAB8FA4BQ36399561-1E6AB42D-7A8F-419C-BDA3-DC9761F2D33CQ36836774-F6284818-BCE7-47E6-A298-4E351FBFAF90Q36847271-DEDC4D46-99E2-4887-B72D-AB661ECCCB2AQ38116807-A3D57731-E7E6-4A0A-847E-85503B469261Q38118061-E0350A73-5F70-46A3-A6EF-884715150BFCQ39143491-39C1B9FA-FFDF-4095-8265-AFC4EDDBE1A4Q45055733-E247AEE5-9655-4A46-A62D-DE1138840A67Q46619166-53095920-7210-4D6A-977A-B4A662759086Q47793861-25EBD6C9-CD87-45A0-B61F-F361355B60DFQ48497066-99C91753-0CD4-44F6-8BB9-7F90BEC9BCB9Q48846598-42BB4910-47F4-4E85-8604-0DEBF831F1A7Q53533094-F89A9727-F716-49CB-B591-893CAFFED99CQ55034448-60F93AB4-32A7-457B-BC00-D84F7031A3AF
P2860
Sertraline for the treatment of depression in Parkinson's disease.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Sertraline for the treatment of depression in Parkinson's disease.
@en
Sertraline for the treatment of depression in Parkinson's disease.
@nl
type
label
Sertraline for the treatment of depression in Parkinson's disease.
@en
Sertraline for the treatment of depression in Parkinson's disease.
@nl
prefLabel
Sertraline for the treatment of depression in Parkinson's disease.
@en
Sertraline for the treatment of depression in Parkinson's disease.
@nl
P2860
P356
P1433
P1476
Sertraline for the treatment of depression in Parkinson's disease.
@en
P2093
Zesiewicz TA
P2860
P304
P356
10.1002/MDS.870120522
P407
P577
1997-09-01T00:00:00Z